期刊文献+

系统性红斑狼疮患者外周血单一核细胞CCR6、CCR8趋化因子受体mRNA的表达 被引量:1

Expression of chemokine receptors (CCR6 and CCR8 ) mRNA in patients with SLE
下载PDF
导出
摘要 目的:探讨趋化因子受体CCR6及CCR8在系统性红斑狼疮(SLE)患者外周血单一核细胞(PBMC)中的表达及与疾病的相关性。方法:收集93例确诊的SLE患者和30例正常对照者的PBMC,提取RNA。应用RT-PCR方法检测研究对象CCR6、CCR8 mRNA表达水平。记录患者临床表现及实验室检查结果。结果:①CCR6 mRNA在PBMC中表达水平:活动期组(0.985±0.257)与对照组(0.229±0.041)相比,两者差异有统计学意义(t=2.910,P=0.006)。活动期组与非活动期组(0.306±0.034)、非活动期组与对照组、患者组(0.641±0.179)与对照组,3组间差异均无统计学意义(P>0.05)。CCR8 mRNA在PBMC中表达水平:活动期组(0.703±0.285)与非活动期组(0.219±0.031)及对照组(0.120±0.018)间比较,差异无统计学意义(P>0.05);非活动期组与对照组、患者组(0.549±0.663)与对照组,两组间差异无统计学意义(P>0.05)。②患者组CCR6 mRNA水平与疾病活动度评分关系:SLE患者组PBMC中CCR6 mRNA表达水平与SLE疾病活动程度指数(SLEDAI)分别作直线相关性分析,CCR6 mRNA水平与SLEDAI(r=0.457,t=4.513,P<0.001)呈正相关。③患者分为两个亚组:具有某些临床表现的与不具临床表现的CCR6mRNA及CCR8 mRNA表达,差异无统计学意义。结论:CCR6 mRNA表达水平在活动期SLE患者比非活动期及对照组增高,与SLEDAI呈正相关。CCR8 mRNA表达水平在SLE患者组与正常对照组差异无统计学意义。CCR6可能参与SLE的发生。 Objective: To investigate the expression of chemokine receptors in the patients with systemic lupus erythematosus (SLE) and its correlation to SLE disease activity index (SLEDAI). Methods: The mRNA expression of CCR6 and CCR8 on the peripheral blood mononuelear cells(PBMC) of 93 SLE patients and 30 healthy controls were detected by reverse transcription-polymerase chain reaction (RT-PCR). Results: The mRNA level of CCR6 in patients with SLE (0.985±0.257)was significantly higher than that of normal controls (0.229±0.041)(t = 2.910,P= 0.006), with positive correlation to the SLEDAI. There was no difference in the level of CCR8 expression. Conclusions: These results suggest that CCR6 might be involved in the pathogenesis of SLE, and the CCR6 level might be a good indicator for the disease activity of SLE.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2009年第5期287-290,共4页 Journal of Clinical Dermatology
基金 国家自然科学基金(30170863) 江苏省自然科学基金(BK2001195) 江苏省医学重点学科建设与人才战略"135工程"基金资助项目
关键词 红斑狼疮 系统性 趋化因子受体 CCR6 CCR8 lupus erythematosus, systemic chemokine receptors, CCR6, CCR8
  • 相关文献

参考文献17

  • 1Varona R, Villares R, Carramolino L, et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses[J]. J Elin Invest. 2001. 107(6): R37-R45.
  • 2Tiffany HL, Lautens LL, Gao JL, et al. Identification of CCR8: a human monocyte and thymus receptor for the CC ehemokine I- 309[J]. J Exp Med, 1997, 186(1): 165-170.
  • 3Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982, 25(11): 1271-1277.
  • 4Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE [J]. Arthritis Rheum, 1992, 35(6): 630-640.
  • 5Nagase H, Miyamasu M, Yamaguchi M, et al. Expression of CX- CR4 in eosinophils: functional analyses and cytokine-mediated regulation[J]. J Immunol, 2000, 164(11): 5935-5943.
  • 6Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes [J]. J Immunol, 2002, 168(12): 6244-6252.
  • 7Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6[J]. Cytokine Growth Factor Rev, 2003, 14 (5): 409-426.
  • 8Hillyer P, Mordelet E, Flynn G, et al. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration[J]. Clin Exp Immunol, 2003, 134(3): 431-441.
  • 9Meissner A, Zilles O, Varona R, et aI.CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress[J]. Blood, 2003, 102(8): 2724-2727.
  • 10Kohler RE, Caon AC, Willenborg DO, et al. A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system[J]. J Immunol, 2003, 170(12): 6298- 6306.

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部